The newest numbers from the health-care sector emerged out of South Orange, New Jersey Monday, where Nephros, Inc. (OTC:NEPH) is headquartered.
Nephros, a commercial stage medical device and commercial products company that develops and sells high performance water purification products, came out with preliminary quarterly results, showing revenues at around $1.7 million, an increase of greater than 75% compared to the same period in 2018.
“Due to the lower probability of outbreaks during cooler weather, the first quarter is the clearest way to understand the growth of our proactive replacement business,” said CEO Daron Evans, adding, "We are pleased with the preliminary results of the first quarter of 2019 and reiterate our previous guidance of full-year revenue of $8.5 to 9.5 million in 2019."
Nephros is a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets.
NEPH shot higher 7.5 cents, or 15%, to 57.5 cents nearing the end of Monday’s session, as more than 86,000 of its shares changed hands.
